E2905
Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid) Alone and in Combination with Epoetin Alfa (Procrit) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia
PNH Registry M07-001
Blood Disorders-Other
PNH Registry
S1117
A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide vs Azacitidine Alone vs. Azacitidine in Combination with Vorinostat for Higher-Risk Myelodysplastic Syndromes and chronic myelomonocytic leukemia(CMML)
834
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial
913
Phase I/II Trial of Concurrent RAD001 (Everolimus) With Temozolomide/Radiation Followed by Adjuvant RAD001/Temozolomide in Newly Diagnosed Glioblastoma
929
A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent(Temozolomide Resistant)Glioblastoma
E3F05
Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
N0574
Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in Patients with One to Three Cerebral Metastases
N107C
A Phase III Trial of Post-Surgical (SRS) Compared with Whole Brain Radiotherapy (WBRT)for Resected Metastatic Brain Disease
R0925
Natural History of Postoperative Cognitive Function, Quality of Life, and Seizure Control in Patients with Supratentorial Low-Risk Grade II Glioma